AstraZeneca's Farxiga is Beneficial to a Wider Pool of Patients Than Previously Indicated, ... - Latest Tweet by Bloomberg

AstraZeneca's Farxiga is beneficial to a wider pool of patients than previously indicated, a study shows, bolstering the blockbuster potential for the diabetes treatment https://t.co/eS85w40lLx— Bloomberg (@business) August 27, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)